Extended Administration of Oral Etoposide and Cyclophosphamide for the Treatment of Advanced Non-Small Cell Lung Cancer

Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress [PMID19900856]

H Wakelee;BW Loo;KH Kernstine;JB Putnam;MJ Edelman;EE Vokes;HJ Schiller;P Baas;N Saijo;A Adjei;G Goss;H Choy;DR Gandara Clinical Lung Cancer 10(6):395-404

PMC number: n/a (review)

The price of success.

SM Grunberg;H Burris III;R Livingston Journal of Clinical Oncology 13:797-798

Extended oral etopside (E) and oral cyclophosphamide (C) for lung cancer

SM Grunberg;J Crowley;R Livingston Lung Cancer 11(Suppl.1):121(#464)

Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small cell lung cancer. A Southwest Oncology Group study.

SM Grunberg;J Crowley;R Livingston;I Gill;SK Williamson;T O'Rourke;T Braun;ME Marshall;JK Weick;SP Balcerzak;RL Martino JCO 11(8):1598-1601

Treatment of stage IV non-small cell lung cancer (NSCLC) with long term administration of oral etoposide (E) and oral cyclophosphamide (C). A Southwest Oncology Group study.

SM Grunberg;I Gill;JJ Crowley;R Livingston ASCO 11:297(#994)

Extended administration of oral etoposide and cyclophosphamide for the treatment of advanced non-small cell lung cancer.

S Grunberg;I Gill;J Crowley;R Livingston Sixth World Conference on Lung Cancer 127:(#472)